Pancreatic cancer cells can regulate their tolerance to chemotherapy depending on what they detect in their surroundings, according to NYU Langone researchers. With that, it’s unlikely that a single ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...

The University of Iowa Health Care Holden Comprehensive Cancer Center has started treating its second patient — the second in the state — with a cellular therapy to fight synovial sarcoma, a rare and ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning ...

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...

Cancer thrives by stealing nutrients. Tumors grow fast because they hijack the body’s resources—especially glucose and fatty acids. But a new study shows there's a way to beat cancer at its own game.

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they’ve been trying to engineer a cell that’s effective against solid tumors, which ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.